Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Schmidt

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Biological Psychiatry|December 28, 2021
Modulating the Endocannabinoid System as a Therapeutic Approach for Posttraumatic Stress Disorder: Could Translational Research on Fear and Extinction Learning Predict Clinical Benefit?Mark E Schmidt
Idrugs : the Investigational Drugs Journal|May 21, 2005
Functional imaging in drug discovery and developmentMark E Schmidt, Liqun Wang
Future Medicinal Chemistry|March 7, 2017
The value of PET ligand discovery to CNS drug developmentMark E Schmidt, José Ignacio Andrés
Psychotherapy and Psychosomatics|July 5, 2002
Treatment approaches to major depressive disorder relapse. Part 1: dose increaseMark E Schmidt, Maurizio Fava, Shuyu Zhang, et al.
Psychotherapy and Psychosomatics|July 5, 2002
Treatment approaches to major depressive disorder relapse. Part 2: reinitiation of antidepressant treatmentMaurizio Fava, Mark E Schmidt, Shuyu Zhang, et al.
EJNMMI Research|February 15, 2013
Profiling of hepatic clearance pathways of Pittsburgh compound B and human liver cytochrome p450 phenotypingAnne Van Vlaslaer, Russell J Mortishire-Smith, Claire Mackie, et al.
Journal of Clinical Psychopharmacology|June 23, 2004
Chronic lithium administration enhances noradrenergic responses to intravenous administration of the alpha2 antagonist idazoxan in healthy volunteersAyşegül Ozerdem, Mark E Schmidt, Husseini K Manji, et al.
Idrugs : the Investigational Drugs Journal|October 31, 2007
Considerations for generic oncology FDG-PET/CT protocol preparation in drug developmentWilliam A Hallett, R Paul Maguire, Timothy J McCarthy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 11, 2010
The Alzheimer's disease neuroimaging initiative: perspectives of the Industry Scientific Advisory BoardMark E Schmidt, Eric Siemers, Peter J Snyder, et al.
Clinical and Translational Science|October 24, 2019
Translational Model-Informed Dose Selection for a Human Positron Emission Tomography Imaging Study of JNJ-54175446, a P2X7 Receptor AntagonistYan Xu, Xin Miao, Paulien Ravenstijn, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Biological Psychiatry|December 28, 2021
Modulating the Endocannabinoid System as a Therapeutic Approach for Posttraumatic Stress Disorder: Could Translational Research on Fear and Extinction Learning Predict Clinical Benefit?Mark E Schmidt
Idrugs : the Investigational Drugs Journal|May 21, 2005
Functional imaging in drug discovery and developmentMark E Schmidt, Liqun Wang
Future Medicinal Chemistry|March 7, 2017
The value of PET ligand discovery to CNS drug developmentMark E Schmidt, José Ignacio Andrés
Psychotherapy and Psychosomatics|July 5, 2002
Treatment approaches to major depressive disorder relapse. Part 1: dose increaseMark E Schmidt, Maurizio Fava, Shuyu Zhang, et al.
Psychotherapy and Psychosomatics|July 5, 2002
Treatment approaches to major depressive disorder relapse. Part 2: reinitiation of antidepressant treatmentMaurizio Fava, Mark E Schmidt, Shuyu Zhang, et al.
EJNMMI Research|February 15, 2013
Profiling of hepatic clearance pathways of Pittsburgh compound B and human liver cytochrome p450 phenotypingAnne Van Vlaslaer, Russell J Mortishire-Smith, Claire Mackie, et al.
Journal of Clinical Psychopharmacology|June 23, 2004
Chronic lithium administration enhances noradrenergic responses to intravenous administration of the alpha2 antagonist idazoxan in healthy volunteersAyşegül Ozerdem, Mark E Schmidt, Husseini K Manji, et al.
Idrugs : the Investigational Drugs Journal|October 31, 2007
Considerations for generic oncology FDG-PET/CT protocol preparation in drug developmentWilliam A Hallett, R Paul Maguire, Timothy J McCarthy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 11, 2010
The Alzheimer's disease neuroimaging initiative: perspectives of the Industry Scientific Advisory BoardMark E Schmidt, Eric Siemers, Peter J Snyder, et al.
Clinical and Translational Science|October 24, 2019
Translational Model-Informed Dose Selection for a Human Positron Emission Tomography Imaging Study of JNJ-54175446, a P2X7 Receptor AntagonistYan Xu, Xin Miao, Paulien Ravenstijn, et al.
Pageof 7